A randomised controlled trial to evaluate the efficacy of a 6-month dietary and physical activity intervention for patients receiving androgen deprivation therapy for prostate cancer

Lifestyle Changes for Improving Disease-specific Quality of Life in Sedentary Men on Long-term Androgen-Deprivation Therapy for Advanced Prostate Cancer: A Randomised Controlled Trial

(2013) Liam Bourke et al.   EUROPEAN UROLOGY

Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database

(2011) Christopher J. Keto et al.   BJU INTERNATIONAL

A prospective, randomized pilot study evaluating the effects of metformin and lifestyle intervention on patients with prostate cancer receiving androgen deprivation therapy

(2011) Jenny P. Nobes et al.   BJU INTERNATIONAL

Lifestyle Intervention in Men with Advanced Prostate Cancer Receiving Androgen Suppression Therapy: A Feasibility Study

(2011) L. Bourke et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes

(2011) R. R. Wing et al.   DIABETES CARE

Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy

(2010) E. J. Hamilton et al.   CLINICAL ENDOCRINOLOGY

Impact of Androgen-Deprivation Therapy on Physical Function and Quality of Life in Men With Nonmetastatic Prostate Cancer

(2010) Shabbir M.H. Alibhai et al.   JOURNAL OF CLINICAL ONCOLOGY

A randomised controlled trial to evaluate the efficacy of a 6 month dietary and physical activity intervention for prostate cancer patients receiving androgen deprivation therapy

(2010) Farhana Haseen et al.   Trials

The effect of androgen deprivation therapy on body composition in men with prostate cancer: Systematic review and meta-analysis

(2010) Farhana Haseen et al.   Journal of Cancer Survivorship

The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis

(2009) Daphne P Guh et al.   BMC PUBLIC HEALTH

Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer

(2009) Lockwood G. Taylor et al.   CANCER

Effects of Home-Based Diet and Exercise on Functional Outcomes Among Older, Overweight Long-term Cancer Survivors

(2009) Miriam C. Morey et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Combined Resistance and Aerobic Exercise Program Reverses Muscle Loss in Men Undergoing Androgen Suppression Therapy for Prostate Cancer Without Bone Metastases: A Randomized Controlled Trial

(2009) Daniel A. Galvão et al.   JOURNAL OF CLINICAL ONCOLOGY

Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy: Observational Study of Veterans With Prostate Cancer

(2009) N. L. Keating et al.   JNCI-Journal of the National Cancer Institute

Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention

(2009) S. Nicole Culos-Reed et al.   SUPPORTIVE CARE IN CANCER

Secular trends in prostate cancer mortality, incidence and treatment: England and Wales, 1975–2004

(2008) Sabina Hussain et al.   BJU INTERNATIONAL

Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer

(2008) Daniel A. Galvão et al.   BJU INTERNATIONAL

Estimating Clinically Meaningful Changes for the Functional Assessment of Cancer Therapy—Prostate: Results from a Clinical Trial of Patients with Metastatic Hormone-Refractory Prostate Cancer

(2008) David Cella et al.   VALUE IN HEALTH